Improved synthesis and pharmacological evaluation of racemic 11-demethylcalanolide a

Yaoxue Xuebao

Volumn 43, Issue 7, 2008, Pages 707-718

  Wang, Lin ^a   Zhang, Xing quan ^b,c   Chen, Hong shan ^b   Tao, Pei zhen ^b   Li, Yan ^a   Bai, Yu ^d   Hu, Jin ping ^a   Ma, Tao ^a   Xing, Zhen tang ^d   Peng, Zong gen ^b   Zhou, Chun mei ^a   Gao, Qi ^a   Liu, Gang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d North China Pharmaceutical Corporation   (China)

Author keywords

Acute toxicity in mice; HIV 1; Racemic 11 demethylcalanolide A; Synergistic effects

Indexed keywords

11 DEMETHYLCALANOLIDE A; 11-DEMETHYLCALANOLIDE A; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTISERUM; INDINAVIR; PYRANOCOUMARIN DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LD 50; MALE; METABOLISM; MOUSE; SYNTHESIS;

ANIMALS; ANTI-HIV AGENTS; DRUG SYNERGISM; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; IMMUNE SERA; INDINAVIR; LETHAL DOSE 50; MALE; MICE; PYRANOCOUMARINS; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 50549083898     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Piot P, Bartos M, Ghys PD, et al. The global impact of HIV/AIDS [J]. Nature, 2001,410:968-973.
2. AIDS info, FDA Approved Drugs, 2008, 3:4. http://www.aidsinfo.nih.gov/ drugs/.[DB]
3. Menendez AL. Target HIV; antiretroviral therapy and development of drug resistance [J]. Trends Pharmacol Sci, 2002,23:381-388.
4. Richman DD. HIV chemotherapy [J]. Nature, 2001, 410:995-1001.
5. Kashman Y, Gustafson KR, Fuller RW, et al. HIV inhibitory natural products. Part 7. The calanolides, a novel HIV inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum [J]. J Med Chem, 1992,35:2735-2743.
6. Zhou CM, Wang L, Zhao ZZ. Synthesis of 11-demethyl and 6,6-demethyl calanolide A [J]. Chin Chem Lett, 1997,8:859-860.
7. Zhou CM, Wang L, Zhang ML, et al. Total synthesis of (±) -calanolide A and its anti-HIV activity [J]. Chin Chem Lett, 1998,9:433-434.
8. Zhou CM, Wang L, Zhang ML, et al. Synthesis and antiHIV activity of (±) -calanolide A and its analogues [J]. Acta Pharm Sin, 1999,34:673-678.
9. Wang L, Zhao ZZ, Liang XT, et al. The application of dypyrano-coumarin compounds for preparing anti-HIV drug; CN, ZL 01129601. 1 [P], 2001-06-21.
10. Merchant JR, Shirali SS, Kamat MS, et al. Synthesis of benzodipyrandiones [J]. Proc Indian Acad Sci, 1977, 85A,524-530.
11. Popp FD, McEwen WE. Polyphosphoric acid as a reagent inorganic chemistry [J]. Chem Rev, 1958,55:377-383.
12. North JT, Kroneathol DR, Pullockaran AJ, et al. Synthesis of 6-cyno-2, 2-dimethyl-2H-1-benzopyran and other substituted 2,2-dimethyl-2H- 1-benzopyrans [J]. J Org Chem, 1995,60:3397-3400.
13. Chenera B, West MI., Finkelslein JA. et al. Total synthesis of (±) -calanolide A a non-nucleoside inhibitor of HIV-I reverse transeriptase [J]. J Org Chem, 1993,58:5605-5606.
14. Zembower DE, Liao S, Flavin MT, et al. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10, 11-dimethyldihydropyran-12-ol ring (ring C) [J]. J Med Chem, 1997,40:1005-1017.
15. Kucherenko A, Flavin MT, Boulanger WA, et al. Novel approach for synthesis of (±)-calanolide A and its anti-HIV activity [J]. Tetrahedron Lett, 1995,36:5475-5478.
16. Sekino K, Kumamoto T, Tanaka T, et al. Concise synthesis of anti-HIV-1 active (+)-inophyllum B and (+) -calanolide A by application of (-) -quinine catalyzed intramolecular oxo-Michael addition [J]. J Org Chem, 2004,69:2760-2769.
17. Caddick S. Microwave assisted organic reactions [J]. Tetrahedron, 1995,36:5475-5478.
18. Katritzky AR, Khashab NM, Kirichenko N, et al. Microwave-assisted preparations of amidrazones and amidoximes [J]. J Org Chem, 2006,71:9051-9056.
19. Gemal AL, Luche JL. Lanthanoids in borohydride in the presence of lunthanoid chloride, synthetic and mechanistic aspects [J]. J Am Chem Soc, 1981,103: 5454-5459.
20. Ma T, Gao Q, Chen ZW, et al. Chemical resolution of (±)-calanolide A, (±)-cordatolide A and their 11-demelhyl analogues [J]. Bioorg Med Chem Lett, 2008, 12:1079-1083.
21. Peng ZQ-, Chen HS, Teng L. Dynamic study of HlV-I reverse transcriptase inhibitor in serum activity of mice [J]. China J Integ Tradit Chin West Med, 2003,23:514-517.
22. Flavin MT, Rizzo JD, Khilevich A, et al. Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers [J]. J Med Chem, 1996,39:1303-1313.
23. Zhang XQ, Sorensen M, Schooley R, et al. Synergistic in vitro antiretroviral activity of a humanized monoclonal anti-CD4 antibody (TNX-355) and enfuvirtide (T-20) [J]. Antimicrob Agents Chemother, 2006,50:2231-2233.
24. Chou TC. The Median-effect Principle and the Combination Index for Quantitation of Synergism and Antagonism [M]. Synergism and antagonism in chemotherapy. Academic Press, San Diego, Calif, USA, 1991:61-102.